Nexys Therapeutics is an early clinical stage company in San Diego focused on tissue-targeting chemistry to solve mechanism-based tox. The targets we work on have strong disease relevance, but have not been developable due to on-target tox. We overcome the tox through tissue-specific drug distribution achieved by creative chemistry design. We have multiple programs in various stages of development focused in cancer, inflammation, and infectious diseases.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 9276 Scranton Rd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.nexystx.com
- Keywords
- Sotira Scientific.
- HQ
- San Diego, California
Nexys Therapeutics Questions
Nexys Therapeutics's website is http://www.nexystx.com
Nexys Therapeutics's LinkedIn profile is https://www.linkedin.com/company/nexys-therapeutics
Nexys Therapeutics has
3 employees.
View email and phone details for 3
employees at Nexys Therapeutics.
Nexys Therapeutics's industry is
Biotechnology Research
Nexys Therapeutics's top competitors are
Os Therapies,
Hansoh Bio,
Recombinant Dna Technologies,
Cre8bio Llc,
Apros Therapeutics, Inc.,
Gnf,
Prescience International,
Embedded Commercial Group, Llc,
Raybalance, Inc.,
Sotira Scientific.
Nexys Therapeutics's categories are Biotechnology Research
Nexys Therapeutics's founding year is 2018
